Hello

A comprehensive view of breast cancer – Bosomshield

The likelihood of breast cancer recurrence is still difficult to predict. Together with nine partners in the EU, we are the first to combine radiological, histo-pathological and clinical data of patients in one model to predict relapse of distant metastases.